SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008727
Filing Date
2022-05-10
Accepted
2022-05-10 07:44:06
Documents
65
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q inzy-20220331.htm   iXBRL 10-Q 1629945
2 EX-10.1 inzy-ex10_1.htm EX-10.1 117699
3 EX-31.1 inzy-ex31_1.htm EX-31.1 21463
4 EX-31.2 inzy-ex31_2.htm EX-31.2 21633
5 EX-32.1 inzy-ex32_1.htm EX-32.1 11746
6 EX-32.2 inzy-ex32_2.htm EX-32.2 11934
7 GRAPHIC img85894016_0.jpg GRAPHIC 9470
  Complete submission text file 0000950170-22-008727.txt   6784022

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inzy-20220331_pre.xml EX-101.PRE 278896
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inzy-20220331.xsd EX-101.SCH 39156
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inzy-20220331_cal.xml EX-101.CAL 36912
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inzy-20220331_def.xml EX-101.DEF 143078
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inzy-20220331_lab.xml EX-101.LAB 381634
59 EXTRACTED XBRL INSTANCE DOCUMENT inzy-20220331_htm.xml XML 1250167
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39397 | Film No.: 22907398
SIC: 2834 Pharmaceutical Preparations